Literature DB >> 14572661

Expression and regulation of NDRG2 (N-myc downstream regulated gene 2) during the differentiation of dendritic cells.

Seung-Chul Choi1, Kwang Dong Kim, Jong-Tae Kim, Jae-Wha Kim, Do-Young Yoon, Yong-Kyung Choe, Yong-Suk Chang, Sang-Gi Paik, Jong-Seok Lim.   

Abstract

We searched for genes with expressions specific to human monocyte-derived dendritic cells (DCs) using differential display reverse transcription-polymerase chain reaction, and found that N-myc downstream regulated gene 2 (NDRG2), a member of a new family of differentiation-related genes, was expressed in DCs. While DCs derived from CD34(+) progenitor cells also showed strong NDRG2 expression, the corresponding mRNA expression was absent in other cell lines including monocytes, B cells, and NK cells. The inhibition of DC differentiation by dexamethasone or vitamin D(3) treatment down-regulated the expression of the NDRG2 gene in DCs. In addition, gene expression was induced in a myelomonocytic leukemia cell line, which is capable of differentiating into DCs in cytokine-conditioned culture. The level of NDRG2 gene expression in DCs was significantly higher than that of other members of the NDRG gene family. Finally, in contrast to the stable NDRG2 expression in CD40-stimulated DCs, the induction of DC maturation by lipopolysaccharide (LPS) resulted in the down-regulation of NDRG2 gene expression. This down-regulation is likely to be due to a modification and subsequent destabilization of NDRG2 mRNA, because co-treating with actinomycin D and LPS significantly blocked this LPS effect. Taken together, our results indicate that NDRG2 is expressed during the differentiation of DCs, and that NDRG2 gene expression is differentially regulated by maturation-inducing stimuli.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14572661     DOI: 10.1016/s0014-5793(03)01030-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  29 in total

1.  NDRG4 protein-deficient mice exhibit spatial learning deficits and vulnerabilities to cerebral ischemia.

Authors:  Hitomi Yamamoto; Koichi Kokame; Tomohiko Okuda; Yukako Nakajo; Hiroji Yanamoto; Toshiyuki Miyata
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

Review 2.  RNA interference: a potent technology in studying and modulating of dendritic cells, and potential in clinical therapy.

Authors:  Fang Cheng; Song He
Journal:  Mol Biol Rep       Date:  2009-09-12       Impact factor: 2.316

3.  Regulation of histone acetylation by NDRG2 in glioma cells.

Authors:  Li Li; Xiaoqin Qin; Ming Shi; Rui Miao; Li Wang; Xinping Liu; Libo Yao; Yanchun Deng
Journal:  J Neurooncol       Date:  2011-09-13       Impact factor: 4.130

4.  Phosphoproteomic analysis reveals site-specific changes in GFAP and NDRG2 phosphorylation in frontotemporal lobar degeneration.

Authors:  Jeremy H Herskowitz; Nicholas T Seyfried; Duc M Duong; Qiangwei Xia; Howard D Rees; Marla Gearing; Junmin Peng; James J Lah; Allan I Levey
Journal:  J Proteome Res       Date:  2010-10-22       Impact factor: 4.466

5.  NDRG2 expression and mutation in human liver and pancreatic cancers.

Authors:  Xiao-Lan Hu; Xin-Ping Liu; Shu-Xin Lin; Yan-Chun Deng; Na Liu; Xia Li; Li-Bo Yao
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

6.  Mass spectrometrical characterization of NDRG2 protein (N-myc-downstream regulated gene 2) and description of two novel phosphorylation sites.

Authors:  Wei-Qiang Chen; Harald Hoeger; Wei-Fei Diao; Arnold Pollak; Gert Lubec
Journal:  Neurochem Res       Date:  2007-06-15       Impact factor: 3.996

7.  NDRG2 suppresses the proliferation of clear cell renal cell carcinoma cell A-498.

Authors:  Jian-Jun Ma; Cheng-Gong Liao; Xue Jiang; Hua-Dong Zhao; Li-Bo Yao; Ting-Yi Bao
Journal:  J Exp Clin Cancer Res       Date:  2010-07-30

8.  NDRG2, a novel regulator of myoblast proliferation, is regulated by anabolic and catabolic factors.

Authors:  Victoria C Foletta; Matthew J Prior; Nicole Stupka; Kate Carey; David H Segal; Sharon Jones; Courtney Swinton; Sheree Martin; David Cameron-Smith; Ken R Walder
Journal:  J Physiol       Date:  2009-02-09       Impact factor: 5.182

9.  NDRG2 expression decreases with tumor stages and regulates TCF/beta-catenin signaling in human colon carcinoma.

Authors:  Young-Jun Kim; Sun Y Yoon; Jong-Tae Kim; Eun Y Song; Hee G Lee; Hyun J Son; Soo Y Kim; Daeho Cho; Inpyo Choi; Joo H Kim; Jae W Kim
Journal:  Carcinogenesis       Date:  2009-02-23       Impact factor: 4.944

10.  Low expression of N-myc downstream-regulated gene 2 (NDRG2) correlates with poor prognosis in hepatoblastoma.

Authors:  Jan Gödeke; Elke Luxenburger; Franziska Trippel; Kristina Becker; Beate Häberle; Josef Müller-Höcker; Dietrich von Schweinitz; Roland Kappler
Journal:  Hepatol Int       Date:  2015-12-08       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.